FI67231B - Foerfarande foer framstaellning av en hypokolesteremisk foerening - Google Patents

Foerfarande foer framstaellning av en hypokolesteremisk foerening Download PDF

Info

Publication number
FI67231B
FI67231B FI801857A FI801857A FI67231B FI 67231 B FI67231 B FI 67231B FI 801857 A FI801857 A FI 801857A FI 801857 A FI801857 A FI 801857A FI 67231 B FI67231 B FI 67231B
Authority
FI
Finland
Prior art keywords
culture
compound
solution
flask
hours
Prior art date
Application number
FI801857A
Other languages
English (en)
Finnish (fi)
Other versions
FI801857A (fi
FI67231C (fi
Inventor
Richard L Monaghan
Alfred W Alberts
Carl H Hoffman
George Albers-Schonberg
Henry Joshua
Maria B Lopez
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27367450&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI67231(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/048,946 external-priority patent/US4231938A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI801857A publication Critical patent/FI801857A/fi
Publication of FI67231B publication Critical patent/FI67231B/fi
Application granted granted Critical
Publication of FI67231C publication Critical patent/FI67231C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/66—Aspergillus

Claims (5)

1. Förfarande för framställning av en hypokolesteremisk förening med formeIn Q J “· l^i Γ CH3 3 C»3 där vid den streckade linjen kan finnas en enkel bindning eller en dubbelbindning, och Q är ΗΟγ-γ° _ eller OH V v kännetecknat därav, att man i ett odlingsmedium odlar en mikroorganism av släktet Aspergillus terreus, och föreningen isoleras ur odlingsmediet.
2. Förfarande enligt patentkravet 1 för framställning av en förening med formeIn 67231 31 ΗΟγ^γ° -Λ 7 ΓΗ ^ 0 f 3 | | i,-Yy' CH3 kännetecknat därav, att man i ett odlingsmedium odlar en mikroorganism av släktet Aspergillus terreus, och föreningen iso-leras ur odlingsmediet.
3. Förfarande enligt patentkravet 2, kännetecknat därav, att den använda mikroorganismens deponeringsnummer är ATCC 20541 eller 20542.
4. Förfarande enligt patentkravet 1 för framställning av en förening med formeln H0v _ 0 OH L\C)H ; f CK^ kännetecknat därav, att man i ett odlingsmedium odlar en mikroorganism av släktet Aspergillus terreus, och föreningen isoleras ur odlingsmediet.
5. Förfarande enligt patentkravet 4, kännetecknat därav, att man använder en mikroorganism med deponerings-numret ATCC 20541 eller 20542.
FI801857A 1979-06-15 1980-06-10 Foerfarande foer framstaellning av en hypokolesteremisk foerening FI67231C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4894679 1979-06-15
US06/048,946 US4231938A (en) 1979-06-15 1979-06-15 Hypocholesteremic fermentation products and process of preparation
US7780779A 1979-09-21 1979-09-21
US7780779 1979-09-21
US11445980A 1980-01-23 1980-01-23
US11445980 1980-01-23

Publications (3)

Publication Number Publication Date
FI801857A FI801857A (fi) 1980-12-16
FI67231B true FI67231B (fi) 1984-10-31
FI67231C FI67231C (fi) 1985-02-11

Family

ID=27367450

Family Applications (1)

Application Number Title Priority Date Filing Date
FI801857A FI67231C (fi) 1979-06-15 1980-06-10 Foerfarande foer framstaellning av en hypokolesteremisk foerening

Country Status (20)

Country Link
EP (1) EP0022478B1 (sv)
AR (1) AR224008A1 (sv)
AT (1) ATE2620T1 (sv)
AU (1) AU535944B2 (sv)
CA (1) CA1161380A (sv)
DD (1) DD157344A5 (sv)
DE (1) DE3062122D1 (sv)
DK (1) DK149003C (sv)
EG (1) EG16957A (sv)
ES (1) ES492384A0 (sv)
FI (1) FI67231C (sv)
GR (1) GR69216B (sv)
IE (1) IE49685B1 (sv)
IL (1) IL60219A (sv)
NO (1) NO155699C (sv)
NZ (1) NZ193922A (sv)
PL (1) PL125843B1 (sv)
PT (1) PT71371B (sv)
RO (1) RO79487A (sv)
ZW (1) ZW13480A1 (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925599B2 (ja) * 1979-02-20 1984-06-19 三共株式会社 新生理活性物質モナコリンｋおよびその製造法
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
DE8533814U1 (de) * 1985-11-30 1986-01-16 Beiersdorf Ag, 2000 Hamburg Vorrichtung zum Spülen des Darmes
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
DE3739882A1 (de) * 1987-11-25 1989-06-08 Bayer Ag Substituierte hydroxylamine
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.
AU618158B2 (en) * 1989-01-07 1991-12-12 Bayer Aktiengesellschaft New substituted pyrido(2,3-d)pyrimidines
DE3911064A1 (de) * 1989-04-06 1990-10-11 Bayer Ag Substituierte 1,8-naphthyridine
FI94339C (sv) 1989-07-21 1995-08-25 Warner Lambert Co Förfarande för framställning av farmaceutiskt användbar /R-(R*,R*)/-2-(4-fluorfenyl)- , -dihydroxi-5-(1-metyletyl)-3-fenyl-4-/(fenylamino)karbonyl/-1H-pyrrol-1-heptansyra och farmaceutiskt användbara salter därav
NZ245713A (en) * 1992-02-10 1994-12-22 Novopharm Ltd Production of the antibiotic lovastatin from genetically engineered aspergillus strains
CA2062023A1 (en) 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
JPH07504568A (ja) * 1992-03-04 1995-05-25 藤沢薬品工業株式会社 ＨＭＧ−ＣｏＡレダクターゼ阻害物質としてのテトラリン誘導体
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
DE4244029A1 (de) * 1992-12-24 1994-06-30 Bayer Ag Neue substituierte Pyridine
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
TW474809B (en) * 1995-07-03 2002-02-01 Sankyo Co A pharmaceutical composition for arteriosclerosis or xanthoma consisting of HMG-CoA reductase inhibitors and insulin sensitizers
EP0795554A3 (en) * 1996-03-05 1998-01-28 Takeda Chemical Industries, Ltd. (Oxo-)xanthene derivatives, their preparation and their use as immunomodulators
ATE327340T1 (de) * 1997-02-20 2006-06-15 Dsm Ip Assets Bv Fermentative herstellung von wertstoffen in industriellem umfang durch verwendung von chemisch definierten media
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
SI9800057A (sl) 1998-02-26 1999-08-31 Krka, Tovarna Zdravil, D.D. Postopek za pripravo simvastatina in njegovih derivatov
EA032476B1 (ru) 2006-07-05 2019-06-28 Астразенека Аб ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ ИНГИБИТОРЫ HMG-CoA-РЕДУКТАЗЫ И ФОСФОДИЭСТЕРАЗЫ 4, ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ ЛЕГКИХ
SI2373609T1 (sl) 2008-12-19 2013-12-31 Krka, D.D., Novo Mesto Uporaba amfifilnih spojin za kontrolirano kristalizacijo statinov in intermediatov statinov
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049495A (en) * 1974-06-07 1977-09-20 Sankyo Company Limited Physiologically active substances and fermentative process for producing the same
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent

Also Published As

Publication number Publication date
ZW13480A1 (en) 1982-02-03
EP0022478B1 (en) 1983-02-23
ES8105389A1 (es) 1981-06-01
AU5901780A (en) 1980-12-18
PT71371B (en) 1981-10-21
DD157344A5 (de) 1982-11-03
IL60219A (en) 1985-05-31
FI801857A (fi) 1980-12-16
PL125843B1 (en) 1983-06-30
NZ193922A (en) 1982-05-25
NO155699B (no) 1987-02-02
DK149003C (da) 1986-08-18
AU535944B2 (en) 1984-04-12
ATE2620T1 (de) 1983-03-15
DE3062122D1 (en) 1983-03-31
EG16957A (en) 1990-06-30
NO801775L (no) 1980-12-16
FI67231C (fi) 1985-02-11
ES492384A0 (es) 1981-06-01
EP0022478A1 (en) 1981-01-21
GR69216B (sv) 1982-05-07
IE801232L (en) 1980-12-15
PL224920A1 (sv) 1981-03-27
RO79487A (ro) 1982-07-06
PT71371A (en) 1980-07-01
AR224008A1 (es) 1981-10-15
IL60219A0 (en) 1980-09-16
DK254180A (da) 1980-12-16
NO155699C (no) 1987-05-13
CA1161380A (en) 1984-01-31
IE49685B1 (en) 1985-11-27
DK149003B (da) 1985-12-16

Similar Documents

Publication Publication Date Title
FI67231B (fi) Foerfarande foer framstaellning av en hypokolesteremisk foerening
US4342767A (en) Hypocholesteremic fermentation products
US4319039A (en) Preparation of ammonium salt of hypocholesteremic fermentation product
US5026554A (en) Method of inhibiting fungal growth using squalene synthetase inhibitors
US4294926A (en) Hypocholesteremic fermentation products and process of preparation
KR830002329B1 (ko) 모나콜린 k의 제조방법
US4231938A (en) Hypocholesteremic fermentation products and process of preparation
US5182298A (en) Cholesterol lowering agents
FI66427B (fi) Foerfarande foer framstaellning av en ny som laekemedel anvaendbar foerening monacolin k
US5283256A (en) Cholesterol-lowering agents
US4294846A (en) Hypocholesteremic fermentation products and products of preparation
US5102907A (en) Novel squalene synthetase inhibitors
US5053425A (en) Novel anti-fungal compounds
US5096923A (en) Novel squalene synthetase inhibitors
AU640756B2 (en) 2,8-dioxabicyclo(3,2,1)octane derivatives,their production from cultures of MF 5447 and MF 5466 and their use as anti hyper cholesterolemics
FI71300B (fi) Foerfarande foer framstaellning av salter och estrar av syran som svarar mot monakolin-k vilka har antihyperkolesteremisk effekt
IE913221A1 (en) Novel squalene synthetase inhibitors
US5132320A (en) Squalene synthetase inhibitors
US5151365A (en) Culture of Asperigillus versicolor and mutants thereof
US5254727A (en) Acyclic tricarboxylic acid compounds
US5244795A (en) Processes for preparing cholesterol lowering compounds
GB2261373A (en) Inhibitors of farnesyl protein transferase as anti-cancer agents
CA2145204A1 (en) Antibiotic agents
US5441987A (en) Antifungal agent
EP0505135A2 (en) Cholesterol lowering agents and antifungal agents

Legal Events

Date Code Title Description
ND Supplementary protection certificate (spc) granted
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L1

Extension date: 20030622

MA Patent expired

Owner name: MERCK & CO INC.